Dossier
Institute of Cancer Research
Coverage of Institute of Cancer Research in the Nexus archive.
- Doctors hail drug that spares bladder cancer patients ‘life-changing’ surgery
Doctors are praising the drug Durvalumab for its ability to prevent bladder cancer tumors from returning and avoid life-changing surgery. A trial led by the London-based Institute of Cancer Research showed promising results for the treatment.
- AI to predict how bowel cancer patients will respond to new NHS drug
An AI tool called PhenMap has been developed to predict how advanced bowel cancer patients will respond to a new NHS drug, aiming to avoid ineffective treatments. Researchers from the Institute of Cancer Research and RCSI University of Medicine and Health Sciences collaborated on this method to improve patient outcomes.